MetaADEDB 2.0 @ LMMD
Afatinib
(ULXXDDBFHOBEHA-CWDCEQMOSA-N)
Structure
SMILES
CN(C/C=C/C(=O)Nc1cc2c(ncnc2cc1O[C@@H]1COCC1)Nc1ccc(c(c1)Cl)F)C
Type(s)
Approved
ATC code(s)
L01XE13
Molecular Formula:
C24H25ClFN5O3
Molecular Weight:
485.938
Log P:
4.5359
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
88.61
CAS Number(s):
439081-18-2; 850140-72-6
Synonym(s)
1.
Afatinib
2.
(2E)-N-(4-(3-Chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide
3.
Afatinib Dimaleate
4.
Afatinib Maleate
5.
BIBW 2992
6.
BIBW-2992
7.
BIBW-2992-MA2
8.
BIBW-2992MA2
9.
BIBW2992
10.
BIBW2992 MA2
11.
Gilotrif
12.
BIBW 2992 MA2
13.
BIBW 2992MA2
External Link(s)
MeSHD000077716
PubChem Compound10184653
BindingDB50322823
ChEBI61390
94698
CHEMBLCHEMBL1173655
DrugBankDB08916
DrugCentral4318
IUPHAR/BPS Guide to PHARMACOLOGY5667
KEGGdr:D09724
Therapeutic Target DatabaseD05UFG
ZINC3976838
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Malignant neoplasm progressionFAERS: 65US FAERS
2VomitingFAERS: 21SIDER
US FAERS
3NauseaFAERS: 16SIDER
US FAERS
4AstheniaFAERS: 14SIDER
US FAERS
5StomatitisFAERS: 14SIDER
US FAERS
6DehydrationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7Weight decreasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
8PneumoniaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
9Respiratory FailureFAERS: 8US FAERS
10General physical health deteriorationFAERS: 7US FAERS
11DizzinessFAERS: 6SIDER
US FAERS
12HeadacheFAERS: 6SIDER
US FAERS
13PruritusFAERS: 6SIDER
US FAERS
14Abdominal PainFAERS: 5US FAERS
15AcneFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
16EmpyemaFAERS: 5US FAERS
17Blood creatinine increasedFAERS: 4US FAERS
18Disease ProgressionFAERS: 4SIDER
US FAERS
19DyspepsiaFAERS: 4SIDER
US FAERS
20FatigueFAERS: 4SIDER
US FAERS
21Lower respiratory tract infectionFAERS: 4US FAERS
22PneumonitisFAERS: 4US FAERS
23SepsisFAERS: 4SIDER
US FAERS
24AphasiaFAERS: 3US FAERS
25AsthmaFAERS: 3US FAERS
26AtelectasisFAERS: 3US FAERS
27CellulitisFAERS: 3US FAERS
28Cerebral InfarctionFAERS: 3US FAERS
29Cerebrovascular accidentFAERS: 3US FAERS
30Deep Vein ThrombosisFAERS: 3US FAERS
31EpistaxisFAERS: 3SIDER
US FAERS
32GastroenteritisFAERS: 3US FAERS
33Intestinal ObstructionFAERS: 3US FAERS
34MalnutritionFAERS: 3SIDER
US FAERS
35OliguriaFAERS: 3US FAERS
36Septic ShockFAERS: 3US FAERS
37SyncopeFAERS: 3US FAERS
38Urinary tract infectionFAERS: 3SIDER
US FAERS
39WheezingFAERS: 3US FAERS
40Acute kidney injuryFAERS: 2US FAERS
41AlopeciaFAERS: 2SIDER
US FAERS
42CheilitisFAERS: 2SIDER
US FAERS
43CholelithiasisFAERS: 2US FAERS
44ConstipationFAERS: 2SIDER
US FAERS
45DeliriumFAERS: 2US FAERS
46Dermatitis acneiformFAERS: 2SIDER
US FAERS
47Device related infectionFAERS: 2US FAERS
48Diabetes MellitusFAERS: 2US FAERS
49Electrolyte imbalanceFAERS: 2US FAERS
50GastritisFAERS: 2US FAERS
51IleusFAERS: 2US FAERS
52InfectionFAERS: 2SIDER
US FAERS
53Memory impairmentFAERS: 2US FAERS
54Nasal inflammationFAERS: 2SIDER
US FAERS
55Non-cardiac chest painFAERS: 2US FAERS
56Toxicity to various agentsFAERS: 2US FAERS
57Abdominal discomfortFAERS: 1US FAERS
58Adenoid cystic carcinoma of salivary glandFAERS: 1US FAERS
59Alanine Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
60AnuriaFAERS: 1US FAERS
61ArthralgiaFAERS: 1US FAERS
62Aspartate Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
63Atrial FibrillationFAERS: 1US FAERS
64Back PainFAERS: 1SIDER
US FAERS
65Bacterial test positiveFAERS: 1US FAERS
66Blood albumin decreasedFAERS: 1US FAERS
67Blood alkaline phosphatase abnormalFAERS: 1US FAERS
68Blood sodium abnormalFAERS: 1US FAERS
69Blood sodium decreasedFAERS: 1US FAERS
70Bone painFAERS: 1US FAERS
71BronchiectasisFAERS: 1US FAERS
72Cardiac TamponadeFAERS: 1US FAERS
73Catheter site infectionFAERS: 1US FAERS
74Catheter site related reactionFAERS: 1US FAERS
75Cerebral ventricle dilatationFAERS: 1US FAERS
76Chest discomfortFAERS: 1US FAERS
77ChromaturiaFAERS: 1US FAERS
78Chronic gastritisFAERS: 1US FAERS
79ChylothoraxFAERS: 1US FAERS
80ColitisFAERS: 1US FAERS
81Completed SuicideFAERS: 1US FAERS
82ConjunctivitisFAERS: 1SIDER
US FAERS
83Consciousness fluctuatingFAERS: 1US FAERS
84Culture positiveFAERS: 1US FAERS
85DisorientationFAERS: 1US FAERS
86Drug ineffectiveFAERS: 1US FAERS
87Epigastric discomfortFAERS: 1US FAERS
88Escherichia urinary tract infectionFAERS: 1US FAERS
89Eye painFAERS: 1US FAERS
90Febrile NeutropeniaFAERS: 1US FAERS
91Flank PainFAERS: 1US FAERS
92Gastric ulcerFAERS: 1US FAERS
93Gene MutationFAERS: 1US FAERS
94HydrothoraxFAERS: 1US FAERS
95HypophagiaFAERS: 1US FAERS
96HypoxiaFAERS: 1US FAERS
97InfluenzaFAERS: 1US FAERS
98Klebsiella sepsisFAERS: 1US FAERS
99MalaiseFAERS: 1US FAERS
100Metabolic acidosisFAERS: 1US FAERS
101Musculoskeletal PainFAERS: 1US FAERS
102MyalgiaFAERS: 1US FAERS
103NeutropeniaFAERS: 1US FAERS
104NocturiaFAERS: 1US FAERS
105PainFAERS: 1US FAERS
106PancreatitisFAERS: 1US FAERS
107Paraneoplastic EncephalomyelitisFAERS: 1US FAERS
108Pathological fractureFAERS: 1US FAERS
109Pericardial effusionFAERS: 1US FAERS
110Peripheral swellingFAERS: 1US FAERS
111PneumothoraxFAERS: 1US FAERS
112Productive CoughFAERS: 1US FAERS
113Pulmonary FibrosisFAERS: 1US FAERS
114Pyogenic granulomaFAERS: 1US FAERS
115SclerodermaFAERS: 1US FAERS
116Sensory level abnormalFAERS: 1US FAERS
117ShockFAERS: 1US FAERS
118Sjogren's SyndromeFAERS: 1US FAERS
119Skin reactionFAERS: 1US FAERS
120Skin toxicityFAERS: 1US FAERS
121SomnolenceFAERS: 1US FAERS
122Stevens-Johnson SyndromeFAERS: 1US FAERS
123ThrombocytopeniaFAERS: 1US FAERS
124TracheobronchitisFAERS: 1US FAERS
125Urinary tract obstructionFAERS: 1US FAERS
126UrticariaFAERS: 1US FAERS
127VasculitisFAERS: 1US FAERS
128VertigoFAERS: 1US FAERS
129Vocal Cord ParalysisFAERS: 1US FAERS
130Wound InfectionFAERS: 1US FAERS
131XerosisFAERS: 1US FAERS
132Aphthous StomatitisSIDER
133Bladder painSIDER
134Blood potassium decreasedSIDER
135Conjunctival irritationSIDER
136CystitisSIDER
137DermatitisSIDER
138Diastolic dysfunctionSIDER
139Dry skinSIDER
140DysgeusiaSIDER
141InfestationSIDER
142KeratitisSIDER
143Lung Neoplasms21322567
21732753
CTD
144Mucosal erosionSIDER
145Nail InfectionSIDER
146Nail bed infectionSIDER
147NasopharyngitisSIDER
148Oropharyngeal painCanada Vigilance: 1Canada Vigilance
149Pulmonary toxicitySIDER
150Rash erythematousCanada Vigilance: 1Canada Vigilance
151Ventricular DysfunctionSIDER
152nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.